Amid a surge in demand, users of the weight loss drug Ozempic are traveling up to 1,000 miles to find doses due to shortages. Spending on GLP-1 drugs like Ozempic and Wegovy has significantly increased, with health entities spending $38.6 billion on these drugs last year, doubling the previous year's expenditure. Senator Bernie Sanders criticized the high costs associated with these drugs, stating, "No drug is worth anything if people cannot afford it." He has announced an investigation into the pricing of these drugs, highlighting that they can cost up to $1,349 a month while manufacturing costs are less than $5. Additionally, it was noted that the potential annual cost of providing GLP-1 drugs to all Americans with obesity could reach $1 trillion, surpassing the cost of the US military.
Weight loss drugs such as Ozempic, Wegovy could spell trouble for the diet industry https://t.co/ZtuhqmxOZ0 https://t.co/lU30LFez03
Novo Nordisk lands back in Sen. Bernie Sanders' crosshairs, this time over steep costs of Ozempic and Wegovy https://t.co/dCOaLBiQYw
Insulin is $35 a month or less for people on Medicare because of our successful fight against Big Pharma. We’re not done — we’ll keep fighting until insulin is $35 a month for everyone. https://t.co/EBkfgpgeRu
Ozempic users travel 1,000 miles for weight loss drug amidst shortage https://t.co/3KNVJiREIB https://t.co/YZRDMCvVwe
Democrats are lowering health care costs for working families: 🟦 4 out of 5 Americans can find ACA health care coverage for less than $10/month. 🟦 Ongoing Medicare price negotiations could lower prescription drug costs by 25% 🟦 Insulin is capped at $35 for Medicare
Injected drugs like Wegovy and its predecessor, the diabetes medication Ozempic, are reshaping the U.S. health and fitness industries. https://t.co/NF71vpSRnJ
Johann Hari, who has struggled with his weight since childhood, decided to try Ozempic and was delighted with the result. Then he talked to scientists about its possible impact on the brain and began to have second thoughts ⬇️ https://t.co/oKNTjTUUrO
#Ozempic, a drug to treat Type 2 #diabetes, has been going viral for its #WeightLoss side-effects. But what happens if you stop taking it? | @mehaksabharwal writes https://t.co/MgBhwZvtsD
What do weight loss drugs mean for a diet industry built on eating less and exercising more? https://t.co/pkkEainBcQ
A Big Week for GLP-1 Drugs https://t.co/jnsxNRoyuU https://t.co/DUx4cZXHZv
Ozempic, a drug to treat Type 2 #diabetes, has been going viral for its #WeightLoss side effects. But what happens if you stop taking it? | @mehaksabharwal writes https://t.co/MgBhwZvtsD
Very interesting question on whether the new GLP-1 drugs will save more money than they cost the healthcare system (and insurance) since it's not yet known how long you need to take these drugs to sustain the benefits (forever?) for #obesity and #diabetes. New studies suggest…
What happens when a best-selling author decides to try Ozempic? He goes down a rabbit hole of research, emerging slimmer but not altogether unconcerned – and with a book about the experience. https://t.co/cttgxsklX8
For too long, life-saving medication has been priced out of reach for those who need it. Proud to have supported the Inflation Reduction Act, which has lowered insulin costs for the over 70,000 residents living with diabetes in the 4th district. https://t.co/6t1XdSn7es
GLP-1 treatments were a main driver of the increase in overall drug spending by health entities like pharmacies and hospitals last year, study shows. https://t.co/XY0dbJtuo5
No drug is worth anything if people cannot afford it. Today, I am launching an investigation into the outrageous prices Americans are charged for Ozempic and Wegovy. No one should have to pay up to $1,349 a month for prescription drugs that cost less than $5 to manufacture. https://t.co/bNToyEV8HG
No drug is worth anything if people cannot afford it. Today, I am launching an investigation into the outrageous Americans are charged for Ozempic and Wegovy. No one should have to pay up to $1,349 a month for prescription drugs that cost less than $5 to manufacture. https://t.co/sBf6kUIhkf
Are GLP-1s the silver bullet for weight loss that many people believe them to be? One obesity medicine physician explains why the market might be smaller than expected: https://t.co/q831GmLSHu #GSExchanges https://t.co/Pspr3BIoeE
“No drug, no matter how great it is, is worth anything if people cannot afford it.” - @SenSanders on Ozempic. https://t.co/pK7iYwFxor
@BrianCDeese recently calculated that providing GLP-1 drugs for all Americans with obesity could soon cost $1 trillion annually. That would make semaglutide more expensive than the US military. https://t.co/ftGTp6Id4e
Spending on GLP-1 drugs has quickly surpassed spending on insulin products in the last few years. https://t.co/ioENrd3ZNx
GLP-1Ra Spending would likely have been even higher if not limited by manufacturing limitations https://t.co/j3pU2UAaZX by @elaineywchen @statnews https://t.co/5DYJrtz0tF https://t.co/laxEmdRl3l
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about GLP-1 spending, Biosimilar patient costs, and more news.. https://t.co/BBAkkq9q2p #pharma #weight #obesity #Alzheimer #Harvard #biosimilars #insulin #Wegovy #Ozempic $NVO $LLY $BIIB $NVS $SNY $ESAIY $CVS $CI $UNH
Two reports out this morning show spending on GLP-1 drugs have surged, and is set to climb still more this year and beyond. Health entities spent $38.6 billion on Ozempic/Wegovy last year (double the year before), making it the top-seller among all drugs https://t.co/P3Vi6ozBcj
Ozempic users are traveling 1,000 MILES to find doses amid shortages of weight loss drug as people scramble to burn fat before summer https://t.co/sCHZf2SoJ6 https://t.co/mQ4wPcOHTP
Weight Loss Drug Users Are Giving Up Their Vices https://t.co/u1h9X6tvt4 https://t.co/XJm7lbCIfp